Cell And Gene Therapies In Rare Disorders Market To Skyrocket Across The 7MM During The Forecast Period (2025–2034) | Delveinsight
The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...
PipelineReview.com9h
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
INGELHEIM, Germany I, 2025 I Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)∗ and OXB,ŧ today announce the start ...
PipelineReview.com9h
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales ...
Congress Lines Up Regulatory Vetoes
The Congressional Review Act can axe costly Biden rules.
TipRanks on MSN12h
Grainger Faces Challenges in Balancing Environmental Initiatives with Regulatory Pressures
W.W. Grainger (GWW) has disclosed a new risk, in the Environmental / Social category. Grainger’s commitment to environmental and social ...
The National Law Review19h
The CEQ has No Clothes: The End of CEQ’s NEPA Regulations and the Future of NEPA Practice
NEPA generally applies to discretionary actions involving federal agencies, including projects carried out by a federal ...
The New York Times18h
World News
Metrics reveal an economy sliding backward. It will be one of the biggest issues in the election set for Sunday. Canada beat the U.S. in a championship game with added meaning because of political ...
OECD21h
Statement on the Two-Pillar Solution to Address the Tax Challenges Arising from the Digitalisation of the Economy
Analysis and insights for driving a rapid transition to net-zero while building resilience to physical climate impacts ...